Skip to main content
Skip to navigation
Skip to accessibility tools
Search bar
Mobile navigation
Return to main H&W ICS website
Search this site
Search
Close search bar
Home
About
About
Return to previous menu
About
Corporate
Corporate
Return to previous menu
Corporate
Publication Scheme
NHS Continuing Healthcare
Safeguarding
Safeguarding
Return to previous menu
Safeguarding
Keep me safe...
Pick up the Phone Campaign
Board Members
Meetings
Meetings
Return to previous menu
Meetings
Board papers
Past meetings
Past Board Papers
News
Documents
Contact us
Contact us
Return to previous menu
Contact us
Stakeholder and Public Liaison and Information Team
Dermatology
You are here:
Home
Documents
Clinical and Prescribing Policies, Guidance and Pathways
Dermatology
Title
Acne Vulgaris - Prescribing Guideline v2.2
Actinic Keratosis - Prescribing Guideline v2.0
Alopecia areata - Advanced Therapy Pathway v1
Atopic Dermatitis - Advanced Therapy Pathway
Atopic Eczema - Prescribing Guideline v1.2
Disease-Modifying Anti-Rheumatic Drugs (DMARD) - Shared Care Guidance v1.1
Eflornithine (Vaniqa) cream for facial hirsutism - Position Statement v1.1
Emollients - Prescribing Guideline v2.1
Omalizumab, Chronic Spontaneous Urticaria - Advanced Therapy Pathway
Potassium Permanganate - Safe Use Guideline v1.1
Psoriasis - Advanced Therapy Pathway
Psoriasis - Prescribing Guideline v3.0
Topical Corticosteroids - Prescribing Guideline v3.0
Back to Clinical and Prescribing Policies, Guidance and Pathways
Reducing health inequalities
Digital innovation
Health and care services
Get involved
Work for us
Latest news
Accessibility tools
Show accessibility tools
Text size:
Increase text size
Decrease text size
Reset text size
Contrast:
Black and white
Blue contrast
Beige contrast
High contrast
Reset contrast
Frank Ltd.
Return to header
Last accessibility toolbar action:
none available